In Depth: U.S.’ Biotech Scrutiny Tests China’s Drugmakers Abroad

U.S. lawmakers’ push to scrutinize biotechnology ties with China is unsettling expectations for Chinese innovative-drug licensing and development deals overseas, threatening a fast-growing channel that has connected local drugmakers with global pharmaceutical companies.